CareDx Files 8-K on Operations & Financial Condition

Ticker: CDNA · Form: 8-K · Filed: Jan 9, 2024 · CIK: 1217234

Complexity: simple

Sentiment: neutral

Topics: financial-condition, regulation-fd, corporate-update

TL;DR

**CareDx just dropped an 8-K about their financials, get ready for the numbers!**

AI Summary

CareDx, Inc. filed an 8-K on January 9, 2024, to report on its results of operations and financial condition, as well as Regulation FD disclosure. This filing indicates that the company is providing an update on its financial performance, which is crucial for investors to understand the company's health and future prospects. For stockholders, this matters because it offers transparency into the company's current financial standing, potentially influencing stock price based on the disclosed results.

Why It Matters

This filing signals that CareDx, Inc. is updating the market on its financial performance, which can directly impact investor confidence and the company's stock valuation. Investors should pay close attention to the specific financial details that will be disclosed.

Risk Assessment

Risk Level: medium — The filing itself is routine, but the undisclosed financial results it references could contain positive or negative news, creating uncertainty for investors.

Analyst Insight

A smart investor would await the full details of the 'Results of Operations and Financial Condition' mentioned in this 8-K before making any investment decisions, as this filing only announces the disclosure, not the specific financial figures.

Key Players & Entities

FAQ

What is the primary purpose of CareDx, Inc.'s 8-K filing on January 9, 2024?

The primary purpose of CareDx, Inc.'s 8-K filing on January 9, 2024, is to report on its Results of Operations and Financial Condition and Regulation FD Disclosure, as indicated by the 'ITEM INFORMATION' sections in the filing.

What is the trading symbol and exchange for CareDx, Inc.'s Common Stock?

CareDx, Inc.'s Common Stock has the trading symbol 'CDNA' and is registered on 'The Nasdaq Stock Market LLC', as stated in the 'Securities registered pursuant to Section 12(b) of the Exchange Act' section.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on 'January 9, 2024', as specified under 'Date of Report (Date of earliest event reported): January 9, 2024'.

What is the business address and phone number of CareDx, Inc.?

CareDx, Inc.'s business address is '8000 Marina Boulevard, Brisbane, California 94005' and its telephone number is '(415) 287-2300', according to the 'BUSINESS ADDRESS' section of the filing.

What is the state of incorporation for CareDx, Inc.?

CareDx, Inc. is incorporated in 'Delaware', as indicated under 'State or Other Jurisdiction of Incorporation' in the filing.

Filing Stats: 669 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2024-01-09 07:10:36

Key Financial Figures

Filing Documents

02

Item 2.02 Results of Operations and Financial Condition. On January 9, 2024, CareDx, Inc. (the "Company") issued a press release announcing its preliminary financial results for the quarter and year ended December 31, 2023. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, including the press release attached hereto as Exhibit 99.1, is intended to be furnished under Item 2.02 and Item 9.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01

Item 7.01 Regulation FD Disclosure. The Company is furnishing an updated corporate presentation, attached as Exhibit 99.2 to this Current Report on Form 8-K (the "Corporate Presentation"), which the Company intends to post on the Company's website. The Corporate Presentation is current as of January 9, 2024, and the Company disclaims any obligation to update this material in the future. The information in this Item 7.01, including the Corporate Presentation attached hereto as Exhibit 99.2, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by CareDx, Inc., dated January 9, 2024. 99.2 Corporate Presentation of CareDx, Inc., dated January 2024. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 9, 2024 CAREDX, INC. By: /s/ Abhishek Jain Abhishek Jain Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing